Strides to merge its Australian biz with Canadian drugmaker Apotex

The company likely to hold 50 per cent stake in the $700 million Australian generic market to create the country's largest generics drugmaker by volume and revenue

Indian pharmaceutical company Strides Shasun on Wednesday said that it would merge its Australian business with the local operations of Canadian drugmaker Apotex Inc to create the country’s largest generics drugmaker by volume and revenue.

Bengaluru-based Strides, which runs its business under the Arrow brand, will have a controlling stake in the merged entity. “Once complete, our merged operation will continue to provide all of the Arrow and Apotex brands that our customers have come to know and trust, and it further enhances our customer service and continuity of supply, to better help pharmacists grow their businesses,” said Dennis Bastas,